VERDE BIO HOLDINGS, INC.
Income Statement
| Line Item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $41.9K | $50.3K | $2.7K |
| Cost of Revenue | — | — | — | — | $0 | $23.3K | $22.1K | $1.8K |
| Gross Profit | — | — | $-1.7K | $0 | $0 | $18.5K | $28.2K | $904 |
| Gross Margin | — | — | — | — | — | 44.3% | 56.0% | 33.2% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | $14.0K | $88.0K | $78.6K | $16.7K |
| Operating Income | $-1.6M | $-3.2M | $-3.0M | $-259.2K | $-37.1K | $-450.8K | $-456.1K | $-196.3K |
| Operating Margin | — | — | — | — | — | -1,077.2% | -906.7% | -7,203.9% |
| Interest Expense | $65.9K | $0 | $366.1K | $231.7K | $350.3K | $299.3K | $181.7K | $19.7K |
| Pretax Income | $-1.8M | $-3.4M | $-3.3M | $-1.6M | $-537.1K | $-1.5M | $-2.1M | $-125.6K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-1.9M | $-3.4M | $0 | $-1.6M | $-537.1K | $-1.5M | $-2.1M | $-125.6K |
| Net Margin | — | — | — | — | — | -3,572.3% | -4,219.9% | -4,610.6% |
| EPS (Basic) | — | $0.00 | $-0.03 | $-1.03 | $-0.01 | $-0.10 | $-2.97 | $-0.01 |
| EPS (Diluted) | — | $0.00 | $-0.03 | $-1.03 | $-0.53 | $-0.10 | $-2.97 | $-0.01 |
| Shares Outstanding (Basic) | 1.68B | 1.28B | 1.16B | 30.0M | 107.4M | 62.9M | 651.8M | 39.8M |
| Shares Outstanding (Diluted) | 1.68B | 1.28B | 1.16B | 30.0M | 107.4M | 62.9M | 651.8M | 39.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |